JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakabayashi, T.
Right arrow Articles by Shimamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakabayashi, T.
Right arrow Articles by Shimamoto, K.

Assessment of Underlying Etiology and Cardiac Sympathetic Innervation to Identify Patients at High Risk of Cardiac Death

Takeru Wakabayashi, Tomoaki Nakata, Akiyoshi Hashimoto, Satoshi Yuda, Kazufumi Tsuchihashi, Mark I. Travin and Kazuaki Shimamoto

Second Department of Internal Medicine (Cardiology), Sapporo Medical University School of Medicine, Sapporo, Japan; and Department of Nuclear Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York



View larger version (90K):

[in a new window]
 
FIGURE 1. Planar early and late 123I-MIBG and 201Tl images of 2 typical patients, 72-y-old man with ISM and sudden cardiac death (A) and 65-y-old woman with ICM and death from heart failure (B). Both early and late cardiac 123I-MIBG uptakes are tremendously reduced in well-perfused hearts; in particular, late H/M was <1.5 in both patients.

 


View larger version (39K):

[in a new window]
 
FIGURE 2. Kaplan–Meier survival curves produced by identified cutoff values of late H/M in patients with ISM (A) and ICM (B). In both ISM and ICM groups, patients with late H/M < 1.82, as identified by overall analysis, show significantly lower survival rates than those with late H/M >= 1.82. Furthermore, when patients with LVEF < 40% are considered, ischemic patients with late H/M < 1.50 and idiopathic patients with late H/M < 2.02 show significantly lower survival rates than each counterpart.

 


View larger version (31K):

[in a new window]
 
FIGURE 3. Annual rate of cardiac death when each group was divided into 4 subgroups based on LVEF of 40% and on identified thresholds of 123I-MIBG activity. For LVEF of <40% and late H/M less than identified thresholds (1.5 for ischemic and 2.02 for idiopathic), annual rates of cardiac death are greatest, 18.2%/y for ischemic group and 11.9%/y for idiopathic group, when subgroup with LVEF of 40% or more and late H/M > 2.02 are excluded because of small number of patients (n = 3).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.